ORGOVYX
Identification of Orgovyx
| No description |
Google image searchProduct monograph
Active ingredient
relugolix, 120 MG
DIN: 02542137
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA SWITZERLAND GMBH
Date: 06-DEC-2023
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BX — Other hormone antagonists and related agents (ATC, ATC/DDD)
- L02BX04 — RELUGOLIX (ATC/DDD)
